文献速递垂体与肾上腺疾病

危重症相关皮质类固醇不足:其非所指与可能所指

Critical Illness-induced Corticosteroid Insufficiency: What It Is Not and What It Could Be.
PubMed 文献 · J Clin Endocrinol Metab · 2022-01-01

危重症以全身皮质醇可利用度升高为特征,是应激反应的一部分。急性应激若合并未充分应激剂量氢化可的松治疗的HPA轴疾病可触发肾上腺危象;应激剂量氢化可的松也用于减少无肾上腺功能不全的感染性休克患者的高血管升压药需求。近10年研究提示上述两种情况均不能称为CIRCI,CIRCI或应用于长期危重症患者可能发生的中枢性肾上腺功能不全。

要点

  • 急性应激合并未充分治疗的HPA轴疾病可触发危及生命的肾上腺危象。
  • 应激剂量氢化可的松用于减少无肾上腺功能不全的感染性休克患者的高血管升压药需求。
  • CIRCI或指长期危重症患者可能发生的中枢性肾上腺功能不全。

核心结论

  • 急性应激合并未充分应激剂量氢化可的松治疗的HPA轴疾病所触发的肾上腺危象不能称为CIRCI。
  • 无肾上腺功能不全的感染性休克中使用应激剂量氢化可的松减少高血管升压药需求不能称为CIRCI。
  • CIRCI或应用于长期危重症患者可能发生的中枢性肾上腺功能不全。

研究设计与样本

  • 综述。

主要发现

  • 持续升高的全身糖皮质激素可利用度主要由循环皮质醇结合蛋白抑制和肝/肾皮质醇代谢抑制所致,对下丘脑/垂体产生负反馈抑制。
  • 高水平的其他糖皮质激素受体配体如胆汁酸和药物如阿片类可进一步抑制ACTH分泌。
  • 肾上腺皮质数周缺乏ACTH介导的营养信号后可能发生结构和功能损害,导致皮质醇产生不足。
  • 这种中枢HPA轴抑制可能因导致持续血管升压药需求和脑病而适应不良,从而阻碍恢复。

临床怎么用

  • 作者建议识别和治疗这一认识不足的CIRCI概念。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Critical illnesses are hallmarked by increased systemic cortisol availability, a vital part of the stress response. Acute stress may trigger a life-threatening adrenal crisis when a disease of the hypothalamic-pituitary-adrenal (HPA) axis is present and not adequately treated with stress doses of hydrocortisone. Stress doses of hydrocortisone are also used to reduce high vasopressor need in patients suffering from septic shock, in the absence of adrenal insufficiency. Research performed over the last 10 years focusing on the HPA axis during critical illness has led to the insight that neither of these conditions can be labeled "critical illness-induced corticosteroid insufficiency" or CIRCI. Instead, these data suggested using the term CIRCI for a condition that may develop in prolonged critically ill patients. Indeed, when patients remain dependent on vital organ support for weeks, they are at risk of acquiring central adrenal insufficiency. The sustained increase in systemic glucocorticoid availability, mainly brought about by suppressed circulating cortisol-binding proteins and suppressed hepatic/renal cortisol metabolism, exerts negative feedback inhibition at the hypothalamus/pituitary, while high levels of other glucocorticoid receptor ligands, such as bile acids, and drugs, such as opioids, may further suppress adrenocorticotropic hormone (ACTH) secretion. The adrenal cortex, depleted from ACTH-mediated trophic signaling for weeks, may become structurally and functionally impaired, resulting in insufficient cortisol production. Such a central HPA axis suppression may be maladaptive by contributing to lingering vasopressor need and encephalopathy, hence preventing recovery. Here, we review this concept of CIRCI and we advise on how to recognize and treat this poorly understood condition.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Téblick A, Gunst J, Van den Berghe G, et al. Critical Illness-induced Corticosteroid Insufficiency: What It Is Not and What It Could Be. J Clin Endocrinol Metab. 2022. PMID: 35358303. doi:10.1210/clinem/dgac201

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。